Concerns about the dangers of birth defects developing in infants born to mothers who used the seizure drug Topamax have forced the Food and Drug Administration to issue warnings about severe consequences that can occur because of the drug’s side effects.
Public records show that the FDA on March 4, 2011 issued a warning in which it notified the public, physicians and others in the health care profession that new medical statistics were raising concerns about the increasing number of cleft lips and palates in newborns that have been linked to mothers who used Topamax during their pregnancies.
The FDA cited figures compiled by the North American Antiepileptic Drug Pregnancy Registry. The federal agency also recommended that all women who took Topamax during pregnancy and all health care professionals who were aware of birth defects related to the drug use to report such problems to the registry and to the FDA.
Johnson & Johnson, the pharmaceutical giant that is the parent of the company producing and distributing Topamax, is currently defending itself against an increasing number of lawsuits filed on behalf of mothers who used Topamax during their pregnancies and gave birth to children with palate issues, heart problems and other defects that the plaintiffs allege were caused by side effects from Topamax. This has caused people to seek out information on Topamax Lawsuits.
These lawyers are experts in drug defect cases and have been providing free consultations to their clients and have been taking the cases on a contingency basis, which means they only collect fees in cases in which there are cash settlements or jury awards.